accountin August 2008, the company's GeneDx subsidiary began accepting samples on a limited basis for hypertrophic cardiomyopathy, genetic testing based on next generation (NextGen) sequencing. In September 2008, the company launched its Second Generation...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Esoteric Testing Pays Big Earnings for Bio-Reference
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account